Skip to main content

Sartorius Ad


  • Tuesday, Feb 6th
    3:00 PM – 5:00 PM EST
    High-throughput Label-free Screening Technologies
    Room/Location:  210C
    Idlir Liko, DPhil (he/him/his) – OMass Therapeutics
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Tuesday, Feb 6th
    3:00 PM – 3:30 PM EST
    Extending applications using ultra-high throughput mass spectrometry beyond biochemical screening
    Room/Location:  210C
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Tuesday, Feb 6th
    3:30 PM – 4:00 PM EST
    High Throughput Screening by Native Mass Spectrometry - Identifying binders, with the desired functionality, to membrane protein and intricate targets.
    Room/Location:  210C
    Idlir Liko, DPhil (he/him/his) – OMass Therapeutics
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Tuesday, Feb 6th
    4:00 PM – 4:30 PM EST
    Midwest AViDD HTS for SARS2-CoV-2 Helicase Inhibitors
    Room/Location:  210C
    Yuka Otsuka (she/her/hers) – The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Tuesday, Feb 6th
    4:30 PM – 5:00 PM EST
    High-throughput affinity selection mass spectrometry assay to discover small molecule ligands for cell surface receptors
    Room/Location:  210C
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Wednesday, Feb 7th
    9:30 AM – 11:30 AM EST
    Innovations in Analytical Techniques and Biophysical Tools for Biomolecular Characterization
    Room/Location:  210C
    Stefan Geschwindner, PhD (he/him/his) – AstraZeneca R&D Gothenburg
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Wednesday, Feb 7th
    9:30 AM – 10:00 AM EST
    Revolutionizing RNA Delivery: Harnessing the Body's Evolved Transport Pathways
    Room/Location:  210C
    Alice Ghidini, PhD, EMBA – Sixfold Bio
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Wednesday, Feb 7th
    10:00 AM – 10:30 AM EST
    Revealing the detail: use of single-molecule magnetic force spectroscopy to provide new views into the dynamics of biomolecular interactions.
    Room/Location:  210C
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Wednesday, Feb 7th
    10:30 AM – 11:00 AM EST
    Catalyzing Confidence: A Comprehensive Strategy for Enhancing DEL Hit Validation in Drug Discovery
    Room/Location:  210C
    Stefan Geschwindner, PhD (he/him/his) – AstraZeneca R&D Gothenburg
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Wednesday, Feb 7th
    11:00 AM – 11:30 AM EST
    High-Throughput Identification of Protein Covalent Binders with Acoustic Ejection Mass Spectrometry
    Room/Location:  210C
    Chang Liu – SCIEX
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Wednesday, Feb 7th
    12:30 PM – 2:30 PM EST
    Biomarker Discovery for Diagnostics and Precision Medicine
    Room/Location:  210C
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Wednesday, Feb 7th
    12:30 PM – 1:00 PM EST
    Application of Omics Analyses using Patient-iPSC Derived Cells for Biomarker Development
    Room/Location:  210C
    Wei Zheng, PhD (he/him/his) – National Center for Advancing Translational Sciences, NIH
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Wednesday, Feb 7th
    1:00 PM – 1:30 PM EST
    Unlocking the Potential of the Human Microbiome for Identifying Disease Diagnostic Biomarkers
    Room/Location:  210C
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Wednesday, Feb 7th
    1:30 PM – 2:00 PM EST
    New End to End Automation Platform for Enhanced clinical specimen testing Efficiency and Precision in Clinical Biomarker Laboratory
    Room/Location:  210C
    Juan Reyes – Moderna Therapeutics
    Advances in Bioanalytics and Biomarkers (Room 210C)
  • Wednesday, Feb 7th
    2:00 PM – 2:30 PM EST
    Simplifying Bio Analytical Assay Development: The Quantum Electrochemical Spectroscopy (QES) Approach
    Room/Location:  210C
    Advances in Bioanalytics and Biomarkers (Room 210C)